About Aethlon Medical, Inc.
https://www.aethlonmedical.comAethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
CEO
James B. Frakes
Compensation Summary
(Year 2022)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-10-20 | Reverse | 1:10 |
| 2025-06-09 | Reverse | 1:8 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NTB FINANCIAL CORP
Shares:21.52K
Value:$56.29K
CORDASCO FINANCIAL NETWORK
Shares:13.6K
Value:$35.56K
BLACKROCK INC.
Shares:7.34K
Value:$19.19K
Summary
Showing Top 3 of 5
About Aethlon Medical, Inc.
https://www.aethlonmedical.comAethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $0 | $1.36M ▼ | $-1.49M ▲ | 0% | $-3.74 ▲ | $-1.33M ▲ |
| Q1-2026 | $0 | $1.64M ▼ | $-1.76M ▲ | 0% | $-8.5 ▲ | $-1.61M ▲ |
| Q4-2025 | $0 | $1.92M ▲ | $-6.25M ▼ | 0% | $-40.1 ▼ | $-6.16M ▼ |
| Q3-2025 | $0 | $1.81M ▼ | $-1.75M ▲ | 0% | $-8.6 ▲ | $-1.73M ▲ |
| Q2-2025 | $0 | $2.9M | $-2.81M | 0% | $-13.8 | $-2.82M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $5.85M ▲ | $7.32M ▲ | $1.58M ▼ | $5.75M ▲ |
| Q1-2026 | $3.77M ▼ | $5.31M ▼ | $1.88M ▼ | $3.42M ▼ |
| Q4-2025 | $5.5M ▲ | $7.36M ▲ | $2.24M ▲ | $5.12M ▲ |
| Q3-2025 | $4.83M ▼ | $6.53M ▼ | $2.19M ▼ | $4.33M ▼ |
| Q2-2025 | $6.86M | $8.85M | $2.83M | $6.02M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $-1.49M ▲ | $-1.66M ▲ | $0 | $3.74M ▲ | $2.09M ▲ | $-1.66M ▲ |
| Q1-2026 | $-1.76B ▼ | $-1.71B ▼ | $0 ▼ | $-5.36M ▼ | $-1.74B ▼ | $-1.71B ▼ |
| Q4-2025 | $-6.25M ▼ | $-1.67M ▲ | $2.19K ▲ | $2.36M ▲ | $686.18K ▲ | $-1.67M ▲ |
| Q3-2025 | $-1.75M ▲ | $-2.01M ▲ | $-2.19K ▼ | $-7.07K ▼ | $-2.03M ▲ | $-2.01M ▲ |
| Q2-2025 | $-2.81M | $-2.21M | $0 | $-3.83K | $-2.21M | $-2.21M |
Revenue by Products
| Product | Q1-2022 | Q2-2022 | Q3-2022 | Q4-2022 |
|---|---|---|---|---|
 Aethlon | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 E S I | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q3-2013 | Q2-2013 | Q3-2015 |
|---|---|---|---|
 Milestone M9 | $0 ▲ | $0 ▲ | $0 ▲ |
| Eighth Milestone | $0 ▲ | $0 ▲ | $0 ▲ |
| MileStoneMTwo | $0 ▲ | $0 ▲ | $0 ▲ |
| MileStoneTwoPointThreePointThreePointOne | $0 ▲ | $0 ▲ | $0 ▲ |
| MileStoneTwoPointTwoPointOnePointFour | $0 ▲ | $0 ▲ | $0 ▲ |
| MileStoneTwoPointTwoPointTwoPointThree | $0 ▲ | $0 ▲ | $0 ▲ |
| Seventh Milestone | $0 ▲ | $0 ▲ | $0 ▲ |
| Sixth Milestone | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
James B. Frakes
Compensation Summary
(Year 2022)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-10-20 | Reverse | 1:10 |
| 2025-06-09 | Reverse | 1:8 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NTB FINANCIAL CORP
Shares:21.52K
Value:$56.29K
CORDASCO FINANCIAL NETWORK
Shares:13.6K
Value:$35.56K
BLACKROCK INC.
Shares:7.34K
Value:$19.19K
Summary
Showing Top 3 of 5